Clinical Trials Browser

Not yet recruiting × OTHER × Myasthenia Gravis × Clear all

NCT07593911 2026-05-18

ArchAid-002

Phase NA Not yet recruiting

Immunoglobulin G4-Related Disease, Arthritis, Rheumatoid, Lupus Nephritis, Multiple Sclerosis, Myasthenia Gravis

NCT07570589 2026-05-11

REAL MG PRO

Not yet recruiting

Myasthenia Gravis

NCT07571525 2026-05-06

TAILOR-MG

Not yet recruiting

Myasthenia Gravis, Thymoma

NCT07499323 2026-04-08

Talquetamab in Patients With Refractory Generalized Myasthenia Gravis

Phase NA Not yet recruiting

Myasthenia Gravis

NCT07512375 2026-04-06

MY-EDUC

Not yet recruiting

Myasthenia Gravis

NCT07298928 2026-03-06

A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis

Phase NA Not yet recruiting

Myasthenia Gravis

NCT07392528 2026-02-11

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Phase EARLY_PHASE1 Not yet recruiting

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica

NCT07372807 2026-01-28

RIPERT-MG

Phase 1/2 Not yet recruiting

Myasthenia Gravis

NCT07333196 2026-01-21

Tongji NADs Cohort

Not yet recruiting

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Guillain-Barre Syndrome, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07337395 2026-01-13

PROMPT

Not yet recruiting

Myasthenia Gravis

NCT07323316 2026-01-07

HARMONY 360

Phase NA Not yet recruiting

Myasthenia Gravis

NCT07125105 2025-08-15

APART-MG

Phase NA Not yet recruiting

Myasthenia Gravis

NCT06978738 2025-05-18

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Phase 1 Not yet recruiting

Classical hematology

Immunoglobulin G4-Related Disease, Anemia, Hemolytic, Autoimmune, Lupus Erythematosus, Systemic, Myasthenia Gravis, Myositis, Scleroderma, Systemic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

NCT06933563 2025-04-18

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

Phase EARLY_PHASE1 Not yet recruiting

Myasthenia Gravis

NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Phase NA Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases

NCT06759948 2025-01-06

KY2024-853

Phase 1 Not yet recruiting

Myasthenia Gravis

NCT06485232 2025-01-01

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Phase EARLY_PHASE1 Not yet recruiting

Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

Phase 4 Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis

NCT06221501 2024-01-24

Perioperative Efgartigimod for Thymoma and Myasthenia Gravis

Phase 2 Not yet recruiting

Myasthenia Gravis